Comparison of filtration properties of hepatitis B virus, hepatitis C virus and simian virus 40 using a polyvinylidene fluoride membrane filter

Vox Sanguinis

Volumn 75, Issue 3, 1998, Pages 181-188

  Oshima, Kevin H ^a,b,c   Evans Strickfaden, Tammy T ^a,b   Highsmith, Anita K ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b PALL CORPORATION   (United States)

^c NEW MEXICO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYVINYLIDENE FLUORIDE;

ARTICLE; BACTERIOPHAGE; BLOOD; COMPARATIVE STUDY; CONTROLLED STUDY; FETAL CALF SERUM; FILTRATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; MEMBRANE FILTER; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVOCATION TEST; PURIFICATION; SIMIAN VIRUS 40; VIRUS CULTURE;

EID: 0031792104     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030984     Document Type: Article

References (20)

1. Sobsey MD: Methods for detecting enteric viruses in water and wastewater; in Berg G, Bodily HL, Lennette EH, (eds): Viruses in Water Washington, American Public Health Association, 1976, pp 89-127.
2. Gerba CP, Staggs CH, Alondie MG: Characterization of sewage solid-associated virus and behavior in natural waters. Water Res 1978;12:805-812.
3. Sobsey MD, Moore RS, Glass JS: Evaluating adsorbent filter performance for enteric virus concentrations in tap water. J Am Water Works Assoc 1981;73:542-548.
4. Sobsey MD, Glass JS: Influence of water quality on enteric virus concentration by microporous filter methods. Appl Environ Microbiol 1984;47:956-960.
5. Oshima KH, Highsmith AK, Ades EW: Removal of influenza A virus, phage T1, and PP7 from fluids with a nylon 0.04-μm membrane filter. Environ Toxicol Water Quality 1994;9:165-170.
6. Oshima KH, Evans-Strickfaden TT, Highsmith AK, Ades EW: The use of a microporous polyvinylidene fluoride (PVDF) membrane filter to separate contaminating viral particles from biologically important proteins. Biologicals 1996;24:137-145.
7. He LF, Ailing D, Popkin T, Shapiro M, Alter HJ, Purcell RH: Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis 1987;156:636-640.
8. Yuasa T, Ishikawa G, Manabe S, Sekiguchi S, Takeuchi K, Miyamura T: The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre. J Gen Virol 1991;72:2021-2024.
9. Kaito M, Watanabe S, Ysukiyama-Kohoar K, Yamaguchi K, Kobayashi Y, Komishi M, Yokoi M, Ishida S, Suzuki S, Kohara M: Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994;75:1755-1760.
10. Spence SL, Pipas JM: Simian virus 40 large T antigen host range domain functions in virion assembly. J Virol 1994;68:4227-4240.
11. Valentine-Thon E: Evaluation of SHARP signal system for enzymatic detection of amplified hepatitis B virus DNA. J Clin Microbiol 1995;33:477-480.
12. Udaykumar, Epstein JS, Hewlett IK: A novel method employing UNG to avoid carry-over contamination in RNA-PCR. Nucleic Acids Res 1993;21:3917-3918.
13. Reed LL, Muench H: A simple method of estimating 50 percent end-points. Am J Hyg 1938;27:493-497.
14. Coetzee WF, Bekker PJ: Pilus-specific, lipid-containing bacteriophages PR4 and PR772: Comparison of physical characteristics of genomes. J Gen Virol 1979;45:195-200.
15. Howatson AF: Oncogenic viruses: A survey of their properties; in Maramorosch K, Kurstak E (eds): Comparative Virology. New York, Academic Press, 1971, pp 510-537.
16. Dane DS, Cameron CH, Briggs M: Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1970;i:695-698.
17. Fiers W: Structure and function of RNA bacteriophages; in Fraenkel-Conrat Wagner H (ed): Comprehensive Virology. New York, Plenum Press, 1979, vol 13, pp 69-204.
18. Oshima KH, Evans-Strickfaden TT, Highsmith AK, Ades EW: The removal of phage T and PP7 and poliovirus from fluids with hollow-fiber ultrafilters with molecular weight cutoffs of 50,000, 13,000, and 6,000. Can J Microbiol 1995;41:316-322.
19. Sekiguchi S, Ito K, Kobayashi M, et al: Possibility of hepatitis B virus (HBV) removal from human plasma using regenerated cellulose hollow fiber (BMM). Membrane 1989;14:253-261.
20. Pall Corporation: DV50 Validation Guide 1995. Port Washington.